Modern Management of Heart Failure

The Primary Care Cardiovascular Society (PCCS) presents its second blended learning series of educational resources.

In light of the recent data and guidance supporting the use of SGLT2is in the treatment of heart failure with reduced ejection fraction, the society is planning to provide guidance to its members around this topic and its place in the modern management of heart failure.

This independent medical education programme is sponsored by Boehringer Ingelheim and Lilly Alliance (The Alliance). The Alliance had no influence over the agenda, programme development, content or selection of faculty. Editorial and content decisions were made solely by the Primary Care Cardiovascular Society and faculty chosen by Primary Care Cardiovascular Society.